Lycium barbarum glycopeptide confers neuroprotection in chronic ocular hypertensive rats: a study investigating visual function, retinal structure, microcirculation, and pyroptosis
Chunlin Zhao, Wei Shi, Xuejing Lu · 2026
Read Lycium barbarum glycopeptide confers neuroprotection in chronic ocular hypertensive rats: a study investigating visual function, retinal structure, microcirculation, and pyroptosis by Chunlin Zhao, Wei Shi, Xuejing Lu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13171487.txt.
Description
Glaucoma damage builds quietly, and a compound from goji berries has shown nerve-protecting promise. Chunlin Zhao, Wei Shi, and Xuejing Lu tested the goji glycopeptide in rats bred into chronic high eye pressure, the standard stand-in for the disease. Over 28 days, treated animals were compared with untreated ones and with a group given a known blocker of pyroptosis, a fiery form of cell death, including a combined-treatment arm.
The untreated rats lost visual function, retinal thickness, and blood flow, with pyroptosis markers switched on. The goji compound blunted all of it about as well as the blocker did, and the two together worked better still; parallel cell experiments agreed. The authors present the compound as a candidate glaucoma therapy that works, at least in part, by keeping that cell-death pathway off.
Catalog record
| CREATOR | Chunlin Zhao, Wei Shi, Xuejing Lu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 43 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |